Plus Therapeutics (PSTV) Misses Q1 EPS by 75c

Plus Therapeutics (NASDAQ: PSTV) reported Q1 EPS of ($0.75). Revenue for the quarter came in at $1.67 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• SanDisk upgraded at JPMorgan after investor day; shares climb